Analysis of Riboflavin Kinase market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
The best way to get this vitamin is by eating foods that are rich in riboflavin. Riboflavin Kinase is found in eggs, nuts, dairy products, meats, broccoli, brewer's yeast, Brussel sprouts, wheat germ, wild rice, mushrooms, soybeans, green leafy vegetables These are the critical co-factors for metabolism leading to energy generation because of this property Riboflavin Kinase provides instant energy and used in dietary supplements, animal feeding and food additives. Vitamin B2 is a water-soluble vitamin that is flushed out of the body daily, so it must be restored each day.
and whole-grain and enriched cereals and bread. Riboflavin Kinase is widely available in the form of Multivitamin/ Multimineral supplements.
COVID-19 pandemic has forced all the countries to impose lockdowns and strict social distancing measures across the globe, flattening the global economic curve. This as a result has disrupted almost every market and the Riboflavin Kinase market has also been affected. COVID-19 pandemic has presented massive disruptions in the demand-supply equilibrium across multiple industries, leading towards economic losses at a global level. The cycles like assembling, improvement, and circulation of proteins have halted because of shutdowns, which will affect the worldwide deals of the compounds. But COVID-19 increased the awareness about healthy and nutritional food.
The post-pandemic period is required to observe extraordinary flood in the utilization of the Riboflavin Kinase, which will at last drive the development of the market during the figure time frame. Rebuilding of interest for food, natural segments, and beautifying agents demonstrates a rewarding climate for the development of the Riboflavin Kinase market after the finish of the viral flare-up. Moreover, major parts in the worldwide Riboflavin Kinase market are zeroing in on the foundation of joint efforts and organizations to convey unrivalled quality items on the lookout.
The Riboflavin Kinase market will be witnessing rapid growth due to the increasing demand for processed food, Riboflavin (Vitamin B2) based supplement in the country and wide applications of the Riboflavin Kinase in the processed food industry. Moreover, innovation in food technology in the country and the increasing awareness about better-quality products, being manufactured by utilizing Riboflavin Kinase, are further driving the market.
Based on regional segmentation, the report “Riboflavin Kinase Market” takes into account six prominent regions including North America, Europe, Latin America, East Asia, South Asia and Oceania and Middle East & Africa.
North America has maintained the leading place in the riboflavin Kinase market, owing to the fastest urbanization & industrialization, product development & technological innovations. In addition, it is also found that increasing the health awareness among people, the rise in per-capita income in North America and the multipurpose uses of Riboflavin Kinase is the dominant key factor which boosts the growth of the riboflavin kinase market in the US market.
The increment in vitamin deficiency in natural Western diets is higher, especially in senior adults. Dairy products like milk and butter are the prominent source of Vitamin B2 and these products are very rare in the North American food markets, which is more likely to give a positive impact on the overall need of the Riboflavin Kinase market.
The Asia-Pacific region is witnessed to have the fastest-growing market of riboflavin kinase and is also expected to have a high demand from the consumer end during the forecasting period.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
The global riboflavin market is competitive and fragmented in nature because of the presence of many regional and domestic players.
are amongst the prominent players in the Riboflavin kinase market across the world.
In order to obtain a dominant position in the globe, emphasis is given on the inorganic growth like merger, expansion, acquisition, partnership and collaboration of the companies along with new product development strategy. These strategies are adopted by the leading companies to boost their brand presence among consumers across the globe.
For example, in September 2017, Eisai Co., Ltd has launched vitamin B2 tablet - Chocola BB Plus, that is one of the major product from the Chocola BB series, in Taiwan, which has the high demand from consumers who are both healthy and beauty conscious across Asia. Also, in July 2018, Vitabiotics launched supplements for hair, nail, and skin under the brand named Perfectil, across the global market, which mostly contained vitamin B2 and niacin as well as minerals like zinc and selenium.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The Riboflavin Kinase report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts, and industry participants across the value chain. The Riboflavin Kinase report provides an in-depth analysis of parent market trends, macroeconomic indicators, and governing factors along with market attractiveness as per segments. The Riboflavin Kinase report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The global Riboflavin Kinase Market is segmented into five categories: Product grade, source, application, form and region.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesPre Book
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
The Riboflavin Kinase market is expected to grow at an 5.1% CAGR from 2021 to 2031
By 2031-end, Riboflavin Kinase sales are likely to reach US$ 227.1 Million
DSM, BASF, DESANO, NB Group, and Hubei Guangji Pharmaceutical are some leading Riboflavin Kinase market players.
Need An Exclusive Report For Your Unique Requirement?